Ads
related to: treatment of cutaneous lupus erythematosus- Important Safety Info
Visit Official HCP Website
for full product information.
- Starting LUPKYNIS®
Get info and resources to help
start your patient on LUPKYNIS®.
- Safety & Efficacy Profile
View LUPKYNIS® results in clinical
trials. Adverse reaction info.
- Physician Resources
Tools for you and your practice
to help you prescribe LUPKYNIS®.
- Important Safety Info
theoxfordcenter.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Acute cutaneous lupus erythematosus is a cutaneous condition characterized by a bilateral malar rash (also known as a "butterfly rash") and lesions that tend to be transient, and that follow sun exposure. [1] The acute form is distinct from chronic and subacute cutaneous lupus erythematosus, which may have different types of skin lesions. [2]
There are a number of other kinds of lupus erythematosus including discoid lupus erythematosus, neonatal lupus, and subacute cutaneous lupus erythematosus. [1] There is no cure for SLE, [1] but there are experimental and symptomatic treatments. [6] Treatments may include NSAIDs, corticosteroids, immunosuppressants, hydroxychloroquine, and ...
Lupus erythematosus is a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. [1] Symptoms of these diseases can affect many different body systems, including joints , skin , kidneys , blood cells , heart , and lungs .
Discoid lupus erythematosus is the most common type of chronic cutaneous lupus (CCLE), an autoimmune skin condition on the lupus erythematosus spectrum of illnesses. [1] [2] It presents with red, painful, inflamed and coin-shaped patches of skin with a scaly and crusty appearance, most often on the scalp, cheeks, and ears.
Litifilimab is an investigational drug being evaluated for the treatment of cutaneous lupus erythematosus and systemic lupus erythematosus. It is an anti- BDCA2 monocolonal antibody. [ 1 ] [ 2 ] [ 3 ]
Certain lupus treatments, which may have hair loss as a side effect. Rashes or sores on the scalp, which can be a symptom of lupus. Discoid lupus erythematosus (DLE) is a type of cutaneous lupus ...
Subacute cutaneous lupus erythematosus (SCLE ) is a clinically distinct subset of cases of lupus erythematosus that is most often present in white women aged 15 to 40, consisting of skin lesions that are scaly and evolve as poly-cyclic annular lesions or plaques similar to those of plaque psoriasis.
Lupus erythematosus tumidus (LET) was reported by Henri Gougerot and Burnier R. in 1930. It is a photosensitive skin disorder, a different subtype of cutaneous lupus erythematosus (CLE) from discoid lupus erythematosus (DLE) or subacute CLE (SCLE). [3] LET is usually found on sun-exposed areas of the body.
Ads
related to: treatment of cutaneous lupus erythematosustheoxfordcenter.com has been visited by 10K+ users in the past month